Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11512312
Treatment of Fuchs' endothelial corneal dystrophy
granted -
US 11510880
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11512141
Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment
granted -
US 11505585
FcRn antagonists and methods of use
granted -
US 11497740
Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
granted -
US 11498963
Anti-LILRB antibodies and their use in detecting and treating cancer
granted -
US 11492604
Transposase polypeptides and uses thereof
granted -
US 11492368
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 11491184
Liquids rich in noble gas and methods of their preparation and use
granted -
US 11492650
Production of seleno-biologics in genomically recoded organisms
granted -
US 11491115
Nanoparticles containing extracellular matrix for drug delivery
granted -
US 11484545
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 11479774
Methods of treating cancer harboring hemizygous loss of TP53
granted -
US 11478489
Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof
granted -
US 11478517
Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof
granted -
US 11479560
OX2R compounds
granted -
US 11471509
Compositions and methods relating to myomaker-induced muscle cell fusion
granted -
US 11472813
OX2R compounds
granted -
US 11472888
Reelin antibodies for treatment of atherosclerosis
granted -
US 11471449
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
granted -
US 11466017
Heterocyclic inhibitors of PTPN11
granted -
US 11459564
Modulation of frataxin expression
granted -
US 11459617
Targeted measure of transcriptional activity related to hormone receptors
granted -
US 11452775
Detection of arginine methylation of EGFR for prediction of resistance to therapy
granted